v3.22.2.2
Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Statement of Cash Flows [Abstract]    
Net income attributable to stockholders $ 208.5 $ 1,240.9
Noncash revenues, expenses, gains and losses included in net income from operations:    
Income from discontinued operations 0.0 (762.0)
Deferred tax expense 65.6 122.3
Depreciation and amortization 140.2 126.0
Net realized losses (gains) on investments, including impairment losses 166.2 (123.2)
Stock based compensation expense 47.2 48.6
Loss on extinguishment of debt 0.9 20.7
Changes in operating assets and liabilities:    
Insurance policy reserves and expenses 2,388.4 1,425.8
Premiums and accounts receivable (384.2) (131.6)
Commissions payable (9.4) (77.4)
Reinsurance recoverable (1,397.2) (518.7)
Reinsurance balance payable 71.8 37.2
Funds withheld under reinsurance 13.2 (8.6)
Deferred acquisition costs and value of business acquired (514.1) (706.6)
Taxes payable (receivable) 49.3 (123.4)
Other assets and other liabilities (508.7) (177.2)
Other (17.9) (17.0)
Net cash provided by operating activities - discontinued operations 0.0 151.2
Net cash provided by operating activities 319.8 527.0
Sales of:    
Fixed maturity securities available for sale 2,310.3 668.9
Equity securities 43.2 10.6
Other invested assets 123.9 124.4
Subsidiary, net of cash transferred 4.8 1,319.6
Maturities, calls, prepayments, and scheduled redemption of:    
Fixed maturity securities available for sale 386.3 730.4
Commercial mortgage loans on real estate 29.1 11.0
Purchases of:    
Fixed maturity securities available for sale (2,681.9) (2,316.9)
Equity securities (27.0) (34.9)
Commercial mortgage loans on real estate (77.0) (95.7)
Other invested assets (91.1) (58.9)
Property and equipment and other (133.9) (131.3)
Subsidiaries, net of cash transferred (16.6)
Change in short-term investments (22.1) (30.2)
Other 0.5 1.5
Net cash used in investing activities - discontinued operations 0.0 (145.2)
Net cash (used in) provided by investing activities (134.9) 36.7
Financing activities    
Issuance of debt, net of issuance costs 0.0 347.2
Repayment of debt (75.9) (419.8)
Acquisition of common stock (557.6) (544.3)
Common stock dividends paid (112.7) (118.5)
Preferred stock dividends paid 0.0 (4.7)
Employee stock purchases and withholdings (21.0) (17.3)
Net cash provided by (used in) financing activities - discontinued operations 0.0 0.0
Net cash used in financing activities (767.2) (757.4)
Effect of exchange rate changes on cash and cash equivalents - continuing operations (42.7) (7.2)
Effect of exchange rate changes on cash and cash equivalents - discontinued operations 0.0 0.2
Effect of exchange rate changes on cash and cash equivalents (42.7) (7.0)
Change in cash and cash equivalents (625.0) (200.7)
Cash and cash equivalents at beginning of period 2,054.8 2,228.6
Cash and cash equivalents at end of period $ 1,429.8 $ 2,027.9